Women with diabetes have lower rates of breast, cervical, and colorectal cancer screening compared with women without diabetes, according to a review published online Oct. 24 in Diabetologia.
Dominika Bhatia, from the University of Toronto, and colleagues conducted a systematic literature review to assess participation in breast, cervical, and colorectal cancer screening among patients with diabetes. The analysis included 37 studies (25 cross-sectional and 12 cohort), with 27 studies on breast, 19 on cervical, and 18 on colorectal cancer screening.
The researchers found that having diabetes was associated with a significantly lower likelihood of breast (odds ratio, 0.83; 95 percent confidence interval, 0.77 to 0.90) and cervical (odds ratio, 0.76; 95 percent confidence interval, 0.71 to 0.81) cancer screening compared with not having diabetes. Rates of colorectal cancer screening were similar across patients with and without diabetes (odds ratio, 0.95; 95 percent confidence interval, 0.86 to 1.06). However, women with diabetes were less likely to receive a colorectal cancer screening test compared with women without diabetes (odds ratio, 0.86; 95 percent confidence interval, 0.77 to 0.97).
“Patients with conditions such as diabetes, which cause a high health care burden and competing demands, may need new cancer screening approaches,” the authors said in a statement.
Source: Oncology Nurse Advisor